Journal of women's health
-
Journal of women's health · Feb 2019
Breast Cancer Screening in Primary Care: A Call for Development and Validation of Patient-Oriented Shared Decision-Making Tools.
The latest recommendations on breast cancer screening in women from 40 to 49 years charge primary care providers (PCPs) with completing shared decision-making with women about screening mammography. However, there is a lack of supportive materials accompanying this directive. ⋯ Neither is an evidence-based patient-centered way to assess values surrounding mammography available. To provide the highest quality care for women of 40-49 years, further research should clarify ways to apply risk assessment and values clarification to individual women.
-
Journal of women's health · Feb 2019
Situational Contexts and Risk Factors Associated with Incapacitated and Nonincapacitated Sexual Assaults Among College Women.
Research has documented multilevel risk factors associated with experiencing incapacitated sexual assault among undergraduate women. Less is known about multilevel risk factors associated with nonincapacitated sexual assault. This study examines and compares the different settings, coercion methods, and relationships in which incapacitated and nonincapacitated sexual assaults occur among undergraduate women. ⋯ The different situational contexts associated with incapacitated and nonincapacitated sexual assaults have important implications for the design of prevention strategies that will effectively target the diverse risk environments in which campus sexual assault occurs.
-
Journal of women's health · Feb 2019
Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations.
There is a new appreciation of the perimenopause-defined as the early and late menopause transition stages as well as the early postmenopause-as a window of vulnerability for the development of both depressive symptoms and major depressive episodes. However, clinical recommendations on how to identify, characterize and treat clinical depression are lacking. To address this gap, an expert panel was convened to systematically review the published literature and develop guidelines on the evaluation and management of perimenopausal depression. ⋯ Proven therapeutic options for depression (i.e., antidepressants, psychotherapy) are the front-line treatments for perimenopausal depression. Although estrogen therapy is not approved to treat perimenopausal depression, there is evidence that it has antidepressant effects in perimenopausal women, particularly those with concomitant vasomotor symptoms. Data on estrogen plus progestin are sparse and inconclusive.
-
Journal of women's health · Feb 2019
Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors.
The Surveillance, Epidemiology, and End Result (SEER) database shows a variable increase in endometrial cancer incidence over time. The objective of this review was to examine published endometrial cancer rates and potential etiologies. ⋯ Endometrial cancer rate increases after the first publication of WHI data in 2002 may be associated with the decreased use of approved estrogen-progestogen therapy, the increase in CBHT use, and the prevalence of obesity and diabetes; potential relationships require further evaluation.